KETALAR

This brand name is authorized in United States. It is also authorized in Canada, Finland, Hong Kong SAR China, Ireland, Japan, New Zealand, Poland, Turkey, UK.

Active ingredients

The drug KETALAR contains one active pharmaceutical ingredient (API):

1	Ketamine UNII O18YUO0I83 - KETAMINE HYDROCHLORIDE
	Ketamine is a rapidly acting general anaesthetic for intravenous or intramuscular use with a distinct pharmacological action. Ketamine hydrochloride produces dissociative anaesthesia characterised by catalepsy, amnesia, and marked analgesia which may persist into the recovery period.
	Read more about Ketamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KETALAR Solution for injection or infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AX03	Ketamine	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00224391, 00224405
FI	Lääkealan turvallisuus- ja kehittämiskeskus	150086
GB	Medicines & Healthcare Products Regulatory Agency	388043, 39890, 39907
HK	Department of Health Drug Office	07196, 07197, 07901
JP	医薬品医療機器総合機構	1119400A1031, 1119400A2038, 1119400A3026
NZ	Medicines and Medical Devices Safety Authority	1039
PL	Rejestru Produktów Leczniczych	100033210, 100033232
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308771056
US	FDA, National Drug Code	42023-113, 42023-114, 42023-115, 52584-037